The Board of Directors declared an Interim Dividend of ₹20 per share on the face value of ₹5 each for the Financial Year 2024-2025. Sandeep Kalra, Chief Executive Officer and Executive Director, ...

IT major Infosys Ltd on Thursday revised its FY25 revenue guidance to 4.5- 5.0 per cent in constant currency from an earlier 3.75-4.5 per cent. It, however, maintained an operating margin of 20 ...

Microsoft reported Q1 FY25 revenues of $65.6 billion, up 16% YOY, fueled by strong performance across key segments and strategic investments in artificial intelligence and innovation. Azure's AI ...

According to Zee Business research, LTTS is expected to register a consolidated net profit of Rs 345 crore for the December quarter, which translates to an increase of 7.9 per cent sequentially. The ...

Infosys raised its constant currency revenue growth guidance for FY25 to 4.5-5 per cent, which is its third consecutive upward revision. This adjustment comes after its earlier guidance of 3.75-4. ...

SCHAUMBURG, Ill., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR, payroll, and spend management software solutions, today ...

Buoyed by the festive season, an increased number of wedding dates, and signs of improving consumer sentiment, the industry is looking forward to a positive second half of FY25, says a report by ...

“We are working towards becoming Ebitda profitable in FY25, and we’re very certain about it. "What we look forward to in the next financial year is launching new products, stabilising them and ...

SCHAUMBURG, Ill., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR, payroll, and spend management software solutions, today ...

Applied Digital reported Q2 FY25 earnings after market hours yesterday. Going into this, I had a bullish view. But the lack of developments in signing a customer activates a key risk. APLD has ...

according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...

As Infosys gears up to announce its third quarter results ending December 31, 2024 (Q3 FY25), all eyes are on the information technology (IT) giant’s performance in a seasonally weak quarter ...